MetLife Investment Management LLC decreased its position in AMETEK, Inc. (NYSE:AME – Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 60,190 shares of the technology company’s stock after selling 1,537 shares during the quarter. MetLife Investment Management LLC’s holdings in AMETEK were worth $10,335,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its stake in shares of AMETEK by 7.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 899 shares of the technology company’s stock worth $157,000 after purchasing an additional 61 shares during the last quarter. MorganRosel Wealth Management LLC raised its holdings in AMETEK by 1.6% during the second quarter. MorganRosel Wealth Management LLC now owns 3,886 shares of the technology company’s stock valued at $648,000 after buying an additional 61 shares in the last quarter. Commerzbank Aktiengesellschaft FI lifted its position in shares of AMETEK by 4.8% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 1,340 shares of the technology company’s stock worth $224,000 after buying an additional 61 shares during the last quarter. First Horizon Advisors Inc. boosted its stake in shares of AMETEK by 2.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,639 shares of the technology company’s stock worth $440,000 after acquiring an additional 62 shares in the last quarter. Finally, Checchi Capital Advisers LLC increased its holdings in shares of AMETEK by 2.9% during the 2nd quarter. Checchi Capital Advisers LLC now owns 2,225 shares of the technology company’s stock valued at $371,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.
AMETEK Trading Down 1.0 %
AMETEK stock opened at $195.10 on Friday. The stock has a market cap of $45.13 billion, a price-to-earnings ratio of 33.99, a price-to-earnings-growth ratio of 3.22 and a beta of 1.16. The company has a quick ratio of 0.84, a current ratio of 1.39 and a debt-to-equity ratio of 0.18. AMETEK, Inc. has a 12 month low of $149.03 and a 12 month high of $198.33. The business has a 50 day moving average price of $178.58 and a two-hundred day moving average price of $171.43.
AMETEK Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be issued a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a yield of 0.57%. AMETEK’s dividend payout ratio is 19.51%.
Insiders Place Their Bets
In related news, insider David F. Hermance sold 6,243 shares of AMETEK stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $190.99, for a total value of $1,192,350.57. Following the completion of the transaction, the insider now directly owns 36,731 shares of the company’s stock, valued at $7,015,253.69. The trade was a 14.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Tony J. Ciampitti sold 16,210 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $197.01, for a total transaction of $3,193,532.10. Following the sale, the insider now directly owns 49,490 shares in the company, valued at approximately $9,750,024.90. This represents a 24.67 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,660 shares of company stock valued at $5,958,141. 0.61% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on AME. TD Cowen cut AMETEK from a “hold” rating to a “sell” rating in a research report on Monday, October 7th. KeyCorp raised their target price on shares of AMETEK from $205.00 to $215.00 and gave the company an “overweight” rating in a research note on Friday, November 22nd. Royal Bank of Canada cut their target price on shares of AMETEK from $216.00 to $215.00 and set an “outperform” rating for the company in a research report on Friday, August 2nd. Wolfe Research raised AMETEK to a “hold” rating in a research report on Wednesday, September 18th. Finally, Mizuho lifted their price objective on AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, AMETEK currently has a consensus rating of “Moderate Buy” and an average price target of $199.29.
Check Out Our Latest Analysis on AMETEK
About AMETEK
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles
- Five stocks we like better than AMETEK
- Technology Stocks Explained: Here’s What to Know About Tech
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- The 3 Best Retail Stocks to Shop for in August
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Does Downgrade Mean in Investing?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.